Back
Ovid Therapeutics Stock Price Chart
Sponsored
OVID
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
16
OVID
Ovid Therapeutics
Last Price:
1.17
Seasonality Move:
-0.74%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is relatively stagnant and OVID is experiencing buying pressure, which is a positive indicator for future bullish movement.
Ovid Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.13 | Buy |
20-day SMA: | 1.15 | Buy |
50-day SMA: | 1.06 | Buy |
200-day SMA: | 2.51 | Sell |
8-day EMA: | 1.13 | Buy |
20-day EMA: | 1.12 | Buy |
50-day EMA: | 1.22 | Sell |
200-day EMA: | 2.16 | Sell |
Ovid Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 53.54 | Buy |
Chaikin Money Flow: | 92348 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.08 - 1.22) | Buy |
Bollinger Bands (100): | (0.7 - 2.72) | Sell |
Ovid Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ovid Therapeutics Stock
Is Ovid Therapeutics Stock a Buy?
- Ovid Therapeutics share price is 1.17 while OVID 8-day simple moving average is 1.13, which is a Buy signal.
- The stock price of OVID is 1.17 while Ovid Therapeutics 20-day SMA is 1.15, which makes it a Buy.
- Ovid Therapeutics 50-day simple moving average is 1.06 while OVID share price is 1.17, making it a Buy technically.
- OVID stock price is 1.17 and Ovid Therapeutics 200-day simple moving average is 2.51, creating a Sell signal.
OVID Technical Analysis vs Fundamental Analysis
Sell
16
Ovid Therapeutics (OVID)
is a Sell
Is Ovid Therapeutics a Buy or a Sell?
-
Ovid Therapeutics stock is rated a Sell
The current Ovid Therapeutics [OVID] share price is $1.17. The Score for OVID is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Ovid Therapeutics Stock Info
Market Cap:
83.04M
Price in USD:
1.17
Share Volume:
92.35K
Ovid Therapeutics 52-Week Range
52-Week High:
4.10
52-Week Low:
0.68
Sell
16
Ovid Therapeutics (OVID)
is a Sell
Ovid Therapeutics Share Price Forecast
-
What is the Ovid Therapeutics stock price today?
The Ovid Therapeutics stock price is 1.17 USD today. -
Will OVID stock go up or go down?
Ovid Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Ovid Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ovid Therapeutics is overvalued.
Is Ovid Therapeutics Stock a Buy?
- Ovid Therapeutics share price is 1.17 while OVID 8-day exponential moving average is 1.13, which is a Buy signal.
- The stock price of OVID is 1.17 while Ovid Therapeutics 20-day EMA is 1.12, which makes it a Buy.
- Ovid Therapeutics 50-day exponential moving average is 1.22 while OVID share price is 1.17, making it a Sell technically.
- OVID stock price is 1.17 and Ovid Therapeutics 200-day simple moving average is 2.16, creating a Sell signal.
Fundamental Analysis of Ovid Therapeutics
Is Ovid Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.50 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.23 per share.
Technical Analysis of Ovid Therapeutics
Should I short Ovid Therapeutics stock?
- OVID Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Ovid Therapeutics is a Buy
- Ovid Therapeutics Relative Strength Index (RSI) is 53.54, which suggest Ovid Therapeutics is overbought
- The Bollinger Bands (25) for Ovid Therapeutics is (1.08 - 1.22), which suggest Ovid Therapeutics is a Sell
- The Bollinger Bands (100) for Ovid Therapeutics is (0.7 - 2.72), which suggest Ovid Therapeutics is a Sell
* Ovid Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.